| Ident. | Authors (with country if any) | Title |
|---|
| 000216 (2013) |
Irina L. Tutykhina [Russie] ; Elena S. Sedova [Russie] ; Irina Y. Gribova [Russie] ; Tatiana I. Ivanova [Russie] ; Lev A. Vasilev [Russie] ; Marina V. Rutovskaya [Russie] ; Andrei A. Lysenko [Russie] ; Maxim M. Shmarov [Russie] ; Denis Y. Logunov [Russie] ; Boris S. Naroditsky [Russie] ; Sergei V. Tillib [Russie] ; Alexander L. Gintsburg [Russie] | Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infection |
| 000623 (2012) |
Tatiana Ye Belokrinitskaya [Russie] ; Anna Yu Trubitsyna [Russie] ; Svetlana V. Ionouchene [Russie] | H1N1 2009 influenza virus infection among pregnant women in Transbaikal, Russia |
| 000689 (2012) |
Natalia A. Ilyushina [États-Unis, Russie] ; Nicolai V. Bovin [Russie] ; Robert G. Webster [États-Unis] | Decreased Neuraminidase Activity Is Important for the Adaptation of H5N1 Influenza Virus to Human Airway Epithelium |
| 000743 (2012) |
Dmitriy N. Sokolov [Russie] ; Vladimir V. Zarubaev [Russie] ; Anna A. Shtro [Russie] ; Marina P. Polovinka [Russie] ; Olga A. Luzina [Russie] ; Nina I. Komarova [Russie] ; Nariman F. Salakhutdinov [Russie] ; Oleg I. Kiselev [Russie] | Anti-viral activity of (-)- and (+)-usnic acids and their derivatives against influenza virus A(H1N1)2009 |
| 000751 (2012) |
Sergey A. Tarasov [Russie] ; Vladimir V. Zarubaev [Russie] ; Evgeniy A. Gorbunov [Russie] ; Svetlana A. Sergeeva [Russie] ; Oleg I. Epstein [Russie] | Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice |
| 000A84 (2011) |
Larisa Rudenko [Russie, Australie] ; Han Van Den Bosch [Pays-Bas] ; Irina Kiseleva [Russie, Australie] ; Alexander Mironov [Russie] ; Anatoly Naikhin [Russie] ; Natalie Larionova [Russie] ; Dimitry Bushmenkov [Russie] | Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries |
| 000B13 (2011) |
T. Ilyicheva [Russie] ; I. Susloparov [Russie] ; A. Durymanov [Russie] ; A. Romanovskaya [Russie] ; K. Sharshov [Russie] ; O. Kurskaya [Russie] ; M. Ignashkina [Russie] ; A. Shestopalov [Russie] | Influenza A/H1N1pdm virus in Russian Asia in 2009-2010 |
| 000C42 (2011) |
Koert J. Stittelaar [Pays-Bas] ; Edwin J. B. Veldhuis Kroeze [Pays-Bas] ; Larisa Rudenko [Russie] ; Rajeev Dhere [Inde] ; Sit Thirapakpoomanunt [Thaïlande] ; Marie Paule Kieny [Suisse] ; Albert D. M. E. Osterhaus [Pays-Bas] | Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets |
| 000C70 (2011) |
Irina L. Tutykhina [Russie] ; Denis Y. Logunov [Russie] ; Dmitriy N. Shcherbinin [Russie] ; Maxim M. Shmarov [Russie] ; Amir I. Tukhvatulin [Russie] ; Boris S. Naroditsky [Russie] ; Alexander L. Gintsburg [Russie] | Development of adenoviral vector-based mucosal vaccine against influenza |
| 001358 (2010) |
Inna Karpenko [Russie] ; Sergey Deev [Russie] ; Oleg Kiselev [Russie] ; Valerey Charushin [Russie] ; Vladimir Rusinov [Russie] ; Eugeney Ulomsky [Russie] ; Ella Deeva [Russie] ; Dmitry Yanvarev [Russie] ; Alexander Ivanov [Russie] ; Olga Smirnova [Russie] ; Sergey Kochetkov [Russie] ; Oleg Chupakhin [Russie] ; Marina Kukhanova [Russie] | Antiviral Properties, Metabolism, and Pharmacokinetics of a Novel Azolo-1,2,4-Triazine-Derived Inhibitor of Influenza A and B Virus Replication |
| 001369 (2010) |
Natalia A. Ilyushina [États-Unis, Russie] ; Alexey M. Khalenkov [États-Unis] ; Jon P. Seiler [États-Unis] ; Heather L. Forrest [États-Unis] ; Nicolai V. Bovin [Russie] ; Henju Marjuki [États-Unis] ; Subrata Barman [États-Unis] ; Robert G. Webster [États-Unis] ; Richard J. Webby [États-Unis] | Adaptation of Pandemic H1N1 Influenza Viruses in Mice |
| 001496 (2009) |
Elena A. Govorkova [États-Unis] ; Natalia A. Ilyushina [États-Unis, Russie] ; Jennifer L. Mcclaren [États-Unis] ; Tri S. P. Naipospos [Indonésie] ; Bounlom Douangngeun [Laos] ; Robert G. Webster [États-Unis] | Susceptibility of Highly Pathogenic H5N1 Influenza Viruses to the Neuraminidase Inhibitor Oseltamivir Differs In Vitro and in a Mouse Model |
| 001843 (2008) |
Hans C. Rümke [Pays-Bas] ; José-Maria Bayas [Espagne] ; José-Ramon De Juanes [Espagne] ; Covadonga Caso [Espagne] ; Jan Hendrik Richardus [Pays-Bas] ; Magda Campins [Espagne] ; Lars Rombo [Suède] ; Xavier Duval [France] ; Viktor Romanenko [Russie] ; Tino F. Schwarz [Allemagne] ; Rustem Fassakhov [Russie] ; Francisco Abad-Santos [Espagne] ; Frank Von Sonnenburg [Allemagne] ; Mamadou Drame [Belgique] ; Roland S Nger [Belgique] ; W. Ripley Ballou [Belgique] | Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial |
| 001904 (2008) |
N. L. Varich [Russie] ; A. K. Gitelman [Russie] ; A. A. Shilov [Russie] ; Y. A. Smirnov [Russie] ; N. V. Kaverin [Russie] | Deviation from the random distribution pattern of influenza A virus gene segments in reassortants produced under non-selective conditions |
| 001A69 (2007) |
Natalia A. Ilyushina [États-Unis, Russie] ; Erich Hoffmann [États-Unis] ; Rachelle Salomon [États-Unis] ; Robert G. Webster [États-Unis] ; Elena A. Govorkova [États-Unis, Russie] | Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice |
| 001C08 (2006) |
XIUHUA LU [États-Unis] ; Lindsay E. Edwards [États-Unis] ; Julia A. Desheva [Russie] ; Doan C. Nguyen [États-Unis] ; Andrey Rekstin [Russie] ; Iain Stephenson [États-Unis] ; Kristy Szretter [États-Unis] ; Nancy J. Cox [États-Unis] ; Larisa G. Rudenko [Russie] ; Alexander Klimov [États-Unis] ; Jacqueline M. Katz [États-Unis] | Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses |
| 001C09 (2006) |
J. A. Desheva [Russie] ; X. H. Lu [États-Unis] ; A. R. Rekstin [Russie] ; L. G. Rudenko [Russie] ; D. E. Swayne [États-Unis] ; N. J. Cox [États-Unis] ; J. M. Katz [États-Unis] ; A. I. Klimov [États-Unis] | Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential |
| 001D25 (2004) |
Nikolai V. Kaverin [Russie] ; Irina A. Rudneva [Russie] ; Natalia A. Ilyushina [Russie] ; Aleksandr S. Lipatov [Russie, États-Unis] ; Scott Krauss [États-Unis] ; Robert G. Webster [États-Unis] | Structural differences among hemagglutinins of influenza A virus subtypes are reflected in their antigenic architecture: Analysis of H9 escape mutants |
| 001E21 (2000) |
K. Okazaki [Japon] ; A. Takada [Japon] ; T. Ito [Japon] ; M. Imai [Japon] ; H. Takakuwa [Japon] ; M. Hatta [Japon] ; H. Ozaki [Japon] ; T. Tanizaki [Japon] ; T. Nagano [Japon] ; A. Ninomiya [Japon] ; V. A. Demenev [Russie] ; M. M. Tyaptirganov [Russie] ; T. D. Karatayeva [Russie] ; S. S. Yamnikova [Russie] ; D. K. Lvov [Russie] ; H. Kida [Japon] | Precursor genes of future pandemic influenza viruses are perpetuated in ducks nesting in Siberia |
